Detalles del proyecto
| Estado | Finalizado |
|---|---|
| Fecha de inicio/Fecha fin | 10/10/18 → 10/1/24 |
Financiación
- Celgene International II Sarl: 68.007,00 US$
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
- Flomenhoft, Deborah (PI)